ALLOS THERAPEUTICS INC Stock-Based Compensation
ALLOS THERAPEUTICS INC reported Stock-Based Compensation of $5.26 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-08-03
- ALLOS THERAPEUTICS INC share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $2.37M, a 16.28% decline year-over-year.
- ALLOS THERAPEUTICS INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $2.90M, a 21.16% decline year-over-year.
- ALLOS THERAPEUTICS INC share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $2.14M, a 39.39% decline year-over-year.
- ALLOS THERAPEUTICS INC share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $2.93M, a 34.77% increase year-over-year.
- ALLOS THERAPEUTICS INC share-based payment arrangement, noncash expense for fiscal 2011 was $11.57M, a 1.29% increase from fiscal 2010.
- ALLOS THERAPEUTICS INC share-based payment arrangement, noncash expense for fiscal 2010 was $11.43M, a 31.64% increase from fiscal 2009.
- ALLOS THERAPEUTICS INC share-based payment arrangement, noncash expense for fiscal 2009 was $8.68M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2012-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $5.26M 10-Q · filed 2012-08-03 | $7.40M derived: sum of 3 quarters · filed 2012-08-03 | $10.34M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $2.90M 10-Q · filed 2012-05-03 | $5.04M derived: sum of 2 quarters · filed 2012-05-03 | $7.97M derived: sum of 3 quarters · filed 2012-05-03 | $10.80M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | $2.14M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | $5.08M derived: sum of 2 quarters · filed 2012-03-26 | $7.90M derived: sum of 3 quarters · filed 2012-08-03 | $11.57M 10-K · filed 2012-03-26 |
| 2011-09-30 | $2.93M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-03-26 | $5.76M derived: sum of 2 quarters · filed 2012-08-03 | $9.43M 10-Q/A · filed 2012-03-26 | $12.96M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $6.50M 10-Q · filed 2012-08-03 | $10.03M derived: sum of 3 quarters · filed 2012-08-03 | $12.21M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $3.67M 10-Q · filed 2012-05-03 | $7.21M derived: sum of 2 quarters · filed 2012-05-03 | $9.38M derived: sum of 3 quarters · filed 2012-05-03 | |
| 2010-12-31 | $3.53M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | $5.71M derived: sum of 2 quarters · filed 2012-03-26 | $11.43M 10-K · filed 2012-03-26 | |
| 2010-09-30 | $2.18M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-26 | $7.89M 10-Q/A · filed 2012-03-26 | ||
| 2010-06-30 | $5.71M 10-Q/A · filed 2012-03-26 | |||
| 2009-12-31 | $8.68M 10-K · filed 2012-03-26 |